戻る
AllRock Bio Secures $50 Million Series A Funding for Pulmonary Hypertension Drug Development
戻る
株式ニュース
テーマ
AllRock Bio Secures $50 Million Series A Funding for Pulmonary Hypertension Drug Development
AllRock Bio Secures $50 Million Series A Funding for Pulmonary Hypertension Drug Development
Edgen Stock
·
Sep 18 2025, 20:13
共有先
共有先
リンクをコピー
ソース：
[1] Former CinCor execs reunite to helm new biotech startup
[2] CinCor team reunites at AllRock with $50M to advance another hypertension drug
[3] AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension - BioSpace
Edgen Stock·Sep 18 2025, 20:13Edgen Stock·Sep 18 2025, 20:13
Edgen Stock·Sep 18 2025, 20:13